Finance

Beta
Lists
600222:SHA
Henan Taloph Pharmaceutical Stock Co Ltd
CNÂ¥8.70
0.00%
(0.00) 1D
Jun 5, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600222...
Open
CNÂ¥8.63
High
CNÂ¥9.05
Low
CNÂ¥8.56
Mkt. cap
4.99B
Avg. vol.
28.75M
Volume
43.86M
P/E ratio
79.03
52-wk high
CNÂ¥9.44
52-wk low
CNÂ¥5.51
EPS
CNÂ¥0.11
Shares outstanding
573.89M
No. of employees
2K
Open
CNÂ¥8.63
High
CNÂ¥9.05
Low
CNÂ¥8.56
Mkt. cap
4.99B
Avg. vol.
28.75M
Volume
43.86M
P/E ratio
79.03
52-wk high
CNÂ¥9.44
52-wk low
CNÂ¥5.51
EPS
CNÂ¥0.11
Shares outstanding
573.89M
No. of employees
2K
News stories
From sources across the web
About Henan Taloph Pharmaceutical Stock Co Ltd
CEO-
Employees2.08K
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitetaloph.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
439.16M
424.47M
570.89M
350.23M
Cost of goods sold
337.41M
324.60M
370.86M
258.41M
Cost of revenue
337.41M
324.60M
370.86M
258.41M
Research and development expenses
12.73M
12.20M
29.68M
16.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60.35M
61.88M
79.43M
55.37M
Operating expense
73.05M
68.41M
142.93M
72.24M
Total operating expenses
410.46M
393.01M
513.79M
330.64M
Operating income
28.70M
31.46M
57.10M
19.58M
Other non operating income
178.34K
-2.98M
-1.42M
-16.75M
EBT including unusual items
21.71M
9.94M
43.21M
2.50M
EBT excluding unusual items
16.51M
14.09M
41.98M
1.04M
Income tax expense
1.74M
2.07M
7.81M
182.07K
Effective tax rate
8.02%
20.81%
18.08%
7.29%
Other operating expenses
4.64M
-3.68M
8.81M
7.52K
Net income
17.82M
5.98M
34.67M
2.60M
Net profit margin
4.06%
1.41%
6.07%
0.74%
Earnings per share
-
-
-
-
Interest and investment income
245.44K
13.87K
1.25M
-
Interest expense
-12.61M
-14.40M
-14.95M
-
Net interest expenses
-12.36M
-14.39M
-13.70M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
42.00M
44.29M
69.96M
32.45M
Gain or loss from assets sale
-
-
23.97K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more